Extra Views
Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis
Purchase or Subscribe
Pages 3370 - 3372
http://dx.doi.org/10.4161/cc.21290
Keywords: DEN-PB, bortezomib, combination treatment, liver cancer, thiostrepton
Authors: Ming Wang, Marianna Halasi, Kasim Kabirov, Aryamitra Banerjee, Jennifer Landolfi, Alexander V. Lyubimov and Andrei L. Gartel
View affiliations
Abstract:
Nanoparticle-encapsulated thiazole antibiotic, thiostrepton, has been shown to be an effective agent for inhibiting tumor growth in solid tumor models through the inhibition of proteasomal activity by the induction of apoptosis in cancer cells. Here, we show the efficacy of thiostrepton-micelles in inhibiting tumor growth in a DEN/PB-induced liver cancer model. We also demonstrate an enhanced anticancer effect of the combination treatment of thiostrepton with bortezomib, another proteasome inhibitor in this liver cancer model.
Received: June 21, 2012; Accepted: June 27, 2012; Published Online: August 16, 2012
Preview:
Full Text - Ahead of Print Available - Log in!
Advertisements
